Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
about
Improved oral absorption of cilostazol via sulfonate salt formation with mesylate and besylateSolid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.A systematic approach to design and prepare solid dispersions of poorly water-soluble drug.Dissolution enhancement of glibenclamide by solid dispersion: solvent evaporation versus a supercritical fluid-based solvent -antisolvent technique.Optimization, ex vivo permeation, and stability study of lipid nanocarrier loaded gelatin capsules for treatment of intermittent claudication.Drug-drug interaction study to assess the effects of atorvastatin co-administration on pharmacokinetics and anti-thrombotic properties of cilostazol in male Wistar rats.Cilostazol-Loaded Poly(ε-Caprolactone) Electrospun Drug Delivery System for Cardiovascular Applications.Formulation of cilostazol spherical agglomerates by crystallo-co-agglomeration technique and optimization using design of experimentation.Enhancement of solubility and dissolution of cilostazol by solid dispersion technique.
P2860
Q30985734-BB4F8118-D42B-4D99-B051-5626D6C1FABAQ37932560-2D17A0EC-6DFA-4E74-AEFA-92B6069EBC88Q40027323-5949C095-9B5D-49CA-B328-80C5947A0613Q41836027-F33F454B-A61C-4185-8B70-2B20C94B0367Q41891300-F8B13C65-9392-4346-AF41-039F70D22D5AQ43574589-221F0106-4D25-48E0-9773-6645FACBD28AQ48170626-54E5BFC4-D719-4934-A1C6-78E457E78A51Q52564509-23F0FCD3-5141-442F-9572-23BF874D07EAQ53241631-3ED03220-5D85-48B3-8E83-1C7116DF2BBC
P2860
Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
@en
Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
@nl
type
label
Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
@en
Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
@nl
prefLabel
Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
@en
Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
@nl
P2860
P1433
P1476
Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
@en
P2093
Sadhana J Rajput
Samir G Patel
P2860
P2888
P304
P356
10.1208/S12249-009-9249-7
P407
P577
2009-05-21T00:00:00Z
P5875
P6179
1001063525